Do popular weight loss drugs weaken your bones? new study investigates
NCT ID NCT07094568
Summary
This study aims to understand how two different weight loss medications affect bone health and body composition in adults with severe obesity. Researchers will follow 72 participants for six months, comparing the effects of tirzepatide (like Mounjaro/Zepbound) and liraglutide (like Saxenda). The main goal is to see if one drug is better at protecting bone strength while helping people lose weight.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY (DISORDER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Laiko General Hospital
RECRUITINGAthens, Attica, 11527, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.